Showing results (11-20 of 89) with videos related to
Sort By:
Pageof 9
Gynecologic Oncology|August 1, 1996
A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group studyH G Ball, J A Blessing, S S Lentz, et al.Genomics|September 11, 2001
Characterization of the homeodomain gene EMX2: sequence conservation, expression analysis, and a search for mutations in endometrial cancersF C Noonan, D G Mutch, M Ann Mallon, et al.American Journal of Obstetrics and Gynecology|December 1, 1990
Proliferative and antiproliferative effects of interferon-gamma and tumor necrosis factor-alpha on cell lines derived from cervical and ovarian malignanciesD G Mutch, L S Massad, M S Kao, et al.Obstetrics and Gynecology|May 1, 1993
Familial peripartum cardiomyopathy after molar pregnancyL S Massad, C K Reiss, D G Mutch, et al.Gynecologic Oncology|September 1, 1989
In vitro analysis of the anticancer potential of tumor necrosis factor in combination with cisplatinD G Mutch, C B Powell, M S Kao, et al.Clinical and Experimental Immunology|March 1, 1990
Reduced natural cytotoxic cell activity in patients receiving cisplatin-based chemotherapy and in mice treated with cisplatinC B Powell, D G Mutch, M S Kao, et al.Gynecologic Oncology|October 1, 1992
The effects of cyclosporin A on the lysis of ovarian cancer cells by cisplatin or adriamycinD G Mutch, T J Herzog, C A Chen, et al.Gynecologic Oncology|February 1, 1996
Loss of heterozygosity of chromosome 3p sequences is an infrequent event in endometrial cancerM F Arlt, T J Herzog, D G Mutch, et al.International Journal of Radiation Oncology, Biology, Physics|November 13, 2001
Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodesP W Grigsby, K Heydon, D G Mutch, et al.The Journal of Reproductive Medicine|March 21, 2001
Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfactionE M Swisher, S Babb, A Whelan, et al.Pageof 9